Skip Nav Destination

Issues

Select Year

Issue

Volume 7, Issue 4

1 April 2023

EISSN 2573-7732

In this Issue

ON THE HORIZON
CLINICAL AND TRANSLATIONAL IMMUNOLOGY
EDITORIAL

ON THE HORIZON

How the Unfolded Protein Response Is a Boon for Tumors and a Bane for the Immune System

Lydia N. Raines; Stanley Ching-Cheng Huang

Immunohorizons (2023) 7 (4): 256–264.

Abstract

View articletitled, How the Unfolded Protein Response Is a Boon for Tumors and a Bane for the Immune System

Open the PDF for in another window

Add to Citation Manager

Current Landscape of IFN-λ: Induction, Inhibition, and Potential Clinical Applications to Treat Respiratory Viral Infections

Iván Martínez-Espinoza; Antonieta Guerrero-Plata

Immunohorizons (2023) 7 (4): 265–272.

Abstract

View articletitled, Current Landscape of IFN-λ: Induction, Inhibition, and Potential Clinical Applications to Treat Respiratory Viral Infections

Open the PDF for in another window

Add to Citation Manager

Beyond Antioxidation: Keap1–Nrf2 in the Development and Effector Functions of Adaptive Immune Cells

Anil Pant; Debolina Dasgupta; Aprajita Tripathi; Kalyani Pyaram

Immunohorizons (2023) 7 (4): 288–298.

Abstract

View articletitled, Beyond Antioxidation: Keap1–Nrf2 in the Development and Effector Functions of Adaptive Immune Cells

Open the PDF for in another window

Add to Citation Manager

CLINICAL AND TRANSLATIONAL IMMUNOLOGY

Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab

Kim Campbell; Katherine Li; Feifei Yang; Patrick Branigan; M. Merle Elloso; Jacqueline Benson; Yevgeniya Orlovsky; Yanqing Chen; Sandra Garcet; James G. Krueger

Immunohorizons (2023) 7 (4): 273–285.

Abstract

View articletitled, Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab

Supplementary data

Open the PDF for in another window

Add to Citation Manager

EDITORIAL

I Haven’t Been Replaced by ChatGPT

Mark H. Kaplan

Immunohorizons (2023) 7 (4): 286–287.

View articletitled, I Haven’t Been Replaced by ChatGPT

Open the PDF for in another window

Add to Citation Manager

Cover Image

Cover Image
Editorial Board

All Issues

RSS Feeds

Current Issue Only

RSS Feed - Advance Access

Open Issues RSS Feed

ON THE HORIZON

How the Unfolded Protein Response Is a Boon for Tumors and a Bane for the Immune System

Current Landscape of IFN-λ: Induction, Inhibition, and Potential Clinical Applications to Treat Respiratory Viral Infections

Beyond Antioxidation: Keap1–Nrf2 in the Development and Effector Functions of Adaptive Immune Cells

CLINICAL AND TRANSLATIONAL IMMUNOLOGY

Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab

EDITORIAL

I Haven’t Been Replaced by ChatGPT

RSS Feeds

Publications

Submit a Manuscript

General Information

Journal Services

Issues

ON THE HORIZON

How the Unfolded Protein Response Is a Boon for Tumors and a Bane for the Immune System

Current Landscape of IFN-λ: Induction, Inhibition, and Potential Clinical Applications to Treat Respiratory Viral Infections

Beyond Antioxidation: Keap1–Nrf2 in the Development and Effector Functions of Adaptive Immune Cells

CLINICAL AND TRANSLATIONAL IMMUNOLOGY

Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab

EDITORIAL

I Haven’t Been Replaced by ChatGPT

Cover Image

RSS Feeds

Publications

Submit a Manuscript

General Information

Journal Services

This Feature Is Available To Subscribers Only